GoodRx Holdings GDRX Income Statement (2019-2026)

NASDAQ GDRX
$3.48 -0.05 (-1.42%)
At close: Sep 4, 2026 · 4:00 PM EDT
Reported Financials

GoodRx Holdings Quarterly Income Statement

Periods 28 quarters
Latest Jun 2026

GoodRx Holdings reported revenue of $200.41M and net income of $8.54M for the quarter ended Jun 2026, down 1.3% year over year. This income statement covers 28 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
195.10M213.26M203.33M191.80M187.32M184.11M183.99M189.68M179.96M196.64M197.88M200.61M195.25M198.58M202.97M203.07M196.03M194.78M194.01M200.41M
Cost of RevenueCost of Rev
11.27M13.93M12.28M18.04M17.39M17.36M16.70M16.34M18.72M15.17M12.47M11.87M11.68M12.19M13.36M13.35M13.42M17.46M20.16M21.00M
Gross Profit
183.83M199.33M191.05M173.75M169.92M166.75M167.29M173.34M161.24M181.47M185.41M188.74M183.57M186.39M189.61M189.72M182.61M177.32M173.85M179.41M
Operating items
Research & DevelopmentR&D
95.65M106.49M92.95M94.34M86.22M84.13M78.52M77.44M91.61M93.75M89.96M93.45M89.87M93.83M84.54M84.87M83.53M78.62M81.05M81.99M
Selling, General & AdministrativeSG&A
35.95M35.37M31.92M34.74M49.55M28.58M29.62M30.21M35.32M30.37M41.11M27.59M25.62M23.55M29.63M28.38M32.01M23.94M26.82M24.81M
Other Operating ExpensesOther Opex
56.51M59.63M58.70M66.77M67.27M69.66M64.54M63.72M91.36M90.81M59.43M59.69M59.36M63.03M65.42M63.01M65.86M69.55M72.12M69.98M
Operating ExpensesOpex
188.10M201.50M183.57M195.84M203.03M182.37M172.68M171.37M218.29M214.93M190.50M180.73M174.84M180.40M179.59M176.26M181.41M172.10M180.00M176.78M
Operating IncomeOp. Inc
7.00M11.76M19.76M-4.05M-15.71M1.74M11.30M18.31M-38.33M-18.29M7.38M19.88M20.41M18.18M23.38M26.81M14.62M22.68M14.01M23.63M
EBIT
7.00M11.76M19.76M-4.05M-15.71M1.74M11.30M18.31M-38.33M-18.29M7.38M19.88M20.41M18.18M23.38M26.81M14.62M22.68M14.01M23.63M
Non-operating items
Non Operating Interest Expenses
5.93M5.90M5.87M6.97M9.48M11.93M13.13M14.05M14.72M14.82M14.64M14.57M12.36M11.36M10.64M10.73M10.83M10.40M9.77M9.81M
Interest & Investment IncomeInt & Inv Inc
0.01M0.02M0.05M0.86M2.92M5.45M7.23M7.81M8.65M8.47M7.55M6.33M4.80M4.59M3.93M2.80M2.31M1.89M1.40M1.02M
Other Non Operating IncomeOther Non Op Inc.
-1.81M-2.20M-2.66M4.70M0.69M0.02M0.62M
Non Operating IncomeNon Op. Inc.
-5.92M-5.89M-5.82M-6.11M-6.56M-6.48M-7.71M-6.24M-8.27M-6.35M-7.09M-8.23M-12.29M-6.77M-6.71M-7.23M-8.52M-8.49M-8.37M-8.17M
Net income details
EBT
1.08M5.87M13.94M-10.16M-22.27M-4.75M3.60M12.07M-46.60M-24.64M0.29M11.65M8.11M11.41M16.67M19.58M6.10M14.19M5.64M15.47M
Tax ProvisionsTaxes
19.15M45.78M1.65M-8.74M19.46M-2.77M6.89M-46.72M-8.11M1.23M1.30M4.95M4.15M4.67M5.62M6.73M4.98M8.77M4.47M6.93M
Profit After TaxPAT
-26.72M-39.91M12.29M-1.42M-41.73M-1.97M-3.29M58.79M-38.49M-25.87M-1.01M6.69M3.96M6.74M11.05M12.84M1.12M5.42M1.17M8.54M
Income from Continuing OperationsIncome (Continuing)
-18.07M-39.91M12.29M-1.42M-41.73M-1.97M-3.29M58.79M-38.49M-25.87M-1.01M6.69M3.96M6.74M11.05M12.84M1.12M5.42M1.17M8.54M
Consolidated Net IncomeConsol Net Inc.
-18.07M-39.91M12.29M-1.42M-41.73M-1.97M-3.29M58.79M-38.49M-25.87M-1.01M6.69M3.96M6.74M11.05M12.84M1.12M5.42M1.17M8.54M
Income towards Parent CompanyParent Net Inc
-18.07M-39.91M12.29M-1.42M-41.73M-1.97M-3.29M58.79M-38.49M-25.87M-1.01M6.69M3.96M6.74M11.05M12.84M1.12M5.42M1.17M8.54M
Net Income towards Common StockholdersNet Income
-18.07M-39.91M12.29M-1.42M-41.73M-1.97M-3.29M58.79M-38.49M-25.87M-1.01M6.69M3.96M6.74M11.05M12.84M1.12M5.42M1.17M8.54M
Additional items
EPS (Basic)
-0.04-0.100.030.00-0.100.00-0.010.14-0.09-0.060.000.020.010.020.030.040.000.020.000.03
EPS (Diluted)
-0.04-0.100.030.00-0.100.00-0.010.14-0.09-0.060.000.020.010.020.030.040.000.020.000.02
Shares Outstanding
411.22M409.98M414.74M412.13M412.96M412.86M412.43M412.22M413.44M410.31M390.05M376.25M379.67M385.74M379.20M356.62M346.78M356.33M340.53M339.28M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
411.22M409.98M427.38M412.13M412.96M412.86M412.43M414.33M413.44M410.31M390.05M384.73M388.50M392.17M379.66M357.16M347.81M356.97M341.42M348.06M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
398.68M400.56M396.13M397.91M396.06M397.02M396.65M396.67M398.36M394.09M374.94M378.61M380.80M382.81M360.81M352.77M341.17M341.05M337.58M340.13M
EBITDA
7.00M11.76M19.76M-4.05M-15.71M1.74M11.30M18.31M-38.33M-18.29M7.38M19.88M20.41M18.18M23.38M26.81M14.62M22.68M14.01M23.63M
Interest ExpensesInt Expense
5.93M5.90M5.87M6.97M9.48M11.93M13.13M14.05M14.72M14.82M14.64M14.57M12.36M11.36M10.64M10.73M10.83M10.40M9.77M9.81M
Tax Rate
1,766.88%779.97%11.84%86.07%-87.39%58.44%191.49%-387.12%17.39%-5.01%444.37%42.52%51.12%40.92%33.69%34.40%81.66%61.78%79.27%44.81%